SBRA:NSD-Sabra Healthcare REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 17.97

Change

-0.26 (-1.43)%

Market Cap

USD 4.32B

Volume

1.59M

Analyst Target

USD 14.65
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ("Senior Housing - Leased"), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
DHC Diversified Healthcare Trust

N/A

USD 0.96B

ETFs Containing SBRA

BYRE Principal Exchange-Traded.. 4.26 % 0.00 %

-0.07 (-0.06%)

USD 0.01B
KBWY Invesco KBW Premium Yield.. 4.09 % 0.35 %

+0.02 (+-0.06%)

USD 0.25B
SRET Global X SuperDividend® .. 4.08 % 0.59 %

N/A

USD 0.23B
GRI GRI Bio Inc. 0.00 % 0.55 %

-0.02 (-0.06%)

N/A
HIPS GraniteShares HIPS US Hig.. 0.00 % 0.70 %

+0.06 (+-0.06%)

N/A
XMMD:LSE Xtrackers - MSCI Emerging.. 0.00 % 0.00 %

+0.22 (+-0.06%)

N/A
SDIV:LSE Global X SuperDividend UC.. 0.00 % 0.00 %

-0.01 (-0.06%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.93% 100% F 83% B
Dividend Return 6.31% 100% F 89% A-
Total Return 32.24% 100% F 85% B
Trailing 12 Months  
Capital Gain 29.19% 50% F 73% C
Dividend Return 8.63% 100% F 89% A-
Total Return 37.81% 50% F 78% C+
Trailing 5 Years  
Capital Gain -21.12% 100% F 35% F
Dividend Return 27.66% 100% F 87% B+
Total Return 6.54% 100% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain -0.24% N/A N/A 42% F
Dividend Return 7.72% N/A N/A 59% D-
Total Return 7.96% N/A N/A 94% A
Risk Return Profile  
Volatility (Standard Deviation) 26.60% N/A N/A 67% D+
Risk Adjusted Return 29.03% N/A N/A 62% D
Market Capitalization 4.32B 100% F 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.